FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to lactic-acid bacteria strain used as a therapeutic agent for treating allergy, as well as to using the above strains for preparing a composition for treating allergy. There are presented the lactic-acid bacteria strain Lactobacillus plantarum CBS120663, the lactic-acid bacteria strain Lactobacillus plantarum CBS120664 and the lactic-acid bacteria strain Lactobacillus fermentum CBS120661. The strains possess an ability to elicit the Th1 and/or Th3 responses, and/or inhibit the Th2 responses, which can be defined by cytokine profiles induced in human peripheral blood mononuclear cells if incubated together with the above strains. What is also presented is using the above strains for preparing the composition for treating allergy.
EFFECT: group of inventions can be effectively used for relieving allergy in the patient.
11 cl, 9 tbl, 3 ex
